Cerapedics receives OK in Europe and Australia to use its i-FACTOR Flex FR biologic bone graft
WESTMINSTER - Cerapedics , a privately held orthobiologics company, announced it has received the CE Mark in Europe and Therapeutic Goods Administration (TGA) listing in Australia for its new... Read More
Thursday January 15, 2015 0 comments
Cerapedics: First i-FACTOR bone graft clinical study shows significant favorable outcomes
WESTMINSTER - Cerapedics announced results from the first prospective clinical study evaluating the safety and efficacy of its i-FACTOR bone graft in anterior lumbar interbody fusion (ALIF)... Read More
Tuesday October 21, 2014 0 comments
Cerapedics closes on $9M loan from GE Capital
WESTMINSTER - Cerapedics , an orthobiologics company focused on developing and commercializing its proprietary synthetic peptide technology program, announced it has closed on a $9 million venture... Read More
Tuesday April 15, 2014 0 comments
Cerapedics treats 10,000th patient with i-FACTOR bone graft
WESTMINSTER - Cerapedics Inc ., a medical device company pioneering the use of peptide-enhanced bone grafting materials in spine, trauma and orthopedic surgery, announced it has treated more... Read More
Monday March 4, 2013 0 comments
Cerapedics secures $19M in equity financing to advance bone graft R&D
WESTMINSTER - Cerapedics Inc. today announced it has completed a Series C round of private equity financing totaling $19 million. The new round was led by new investors Medimmune Ventures... Read More
Wednesday December 12, 2012 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
